Related Experiment Video
Updated: Dec 18, 2025

Analysis of RNA Processing Reactions Using Cell Free Systems: 3' End Cleavage of Pre-mRNA Substrates in vitro
Published on: May 3, 2014
Recent molecular insights into canonical pre-mRNA 3'-end processing
Yadong Sun1, Keith Hamilton1, Liang Tong1
1Department of Biological Sciences, Columbia University , New York, NY, USA.
Abstract:
The majority of eukaryotic messenger RNA precursors (pre-mRNAs) undergo cleavage and polyadenylation at their 3' end. This canonical 3'-end processing depends on sequence elements in the pre-mRNA as well as a mega-dalton protein machinery. The cleavage site in mammalian pre-mRNAs is located between an upstream poly(A) signal, most frequently an AAUAAA hexamer, and a GU-rich downstream sequence element. This review will summarize recent advances from the studies on this canonical 3'-end processing machinery. They have revealed the molecular mechanism for the recognition of the poly(A) signal and provided the first glimpse into the overall architecture of the machinery. The studies also show that the machinery is highly dynamic conformationally, and extensive re-arrangements are necessary for its activation. Inhibitors targeting the active site of the CPSF73 nuclease of this machinery have anti-cancer, anti-inflammatory and anti-protozoal effects, indicating that CPSF73 and pre-mRNA 3'-end processing in general are attractive targets for drug discovery.
Abbreviations:
APA: alternative polyadenylation; β-CASP: metallo-β-lactamase-associated CPSF Artemis SNM1/PSO2; CTD: C-terminal domain; CF: cleavage factor; CPF: cleavage and polyadenylation factor; CPSF: cleavage and polyadenylation specificity factor; CstF: cleavage stimulation factor; DSE: downstream element; HAT: half a TPR; HCC: histone pre-mRNA cleavage complex; mCF: mammalian cleavage factor; mPSF: mammalian polyadenylation specificity factor; mRNA: messenger RNA; nt: nucleotide; NTD: N-terminal domain; PAP: polyadenylate polymerase; PAS: polyadenylation signal; PIM: mPSF interaction motif; Poly(A): polyadenylation, polyadenylate; Pol II: RNA polymerase II; pre-mRNA: messenger RNA precursor; RRM: RNA recognition module, RNA recognition motif; snRNP: small nuclear ribonucleoprotein; TPR: tetratricopeptide repeat; UTR: untranslated region; ZF: zinc finger.
Insights
Eukaryotic pre-mRNA 3' end processing involves cleavage and polyadenylation, a process crucial for gene expression. Recent studies reveal the machinery
Area of Science:
- Molecular Biology
- RNA Processing
- Biochemistry
Background:
- Most eukaryotic messenger RNA precursors (pre-mRNAs) require 3' end cleavage and polyadenylation for proper function.
- This canonical process relies on specific sequence elements within the pre-mRNA and a large protein complex.
- Key sequence elements include an upstream polyadenylation signal (PAS), typically AAUAAA, and a downstream GU-rich element.
Purpose of the Study:
- To review recent advancements in understanding the canonical pre-mRNA 3' end processing machinery.
- To elucidate the molecular mechanisms of poly(A) signal recognition and the overall architecture of the processing complex.
- To highlight the potential of targeting this machinery for therapeutic interventions.
Main Methods:
- Review of recent scientific literature focusing on pre-mRNA 3' end processing.
- Analysis of studies detailing the molecular mechanisms of poly(A) signal recognition.
- Examination of research on the dynamic conformational changes and architecture of the processing machinery.
Main Results:
- Recent studies have elucidated the molecular basis for poly(A) signal recognition by the processing machinery.
- The overall architecture of the mega-dalton protein machinery involved in 3' end processing has been revealed.
- The machinery is conformationally dynamic, requiring significant rearrangements for activation.
Conclusions:
- CPSF73 nuclease, a key component of the processing machinery, is a potential drug target.
- Inhibitors of CPSF73 exhibit anti-cancer, anti-inflammatory, and anti-protozoal activities.
- Pre-mRNA 3' end processing represents a promising avenue for drug discovery.
Related Concept Videos
Pre-mRNA Processing: Modification of pre-mRNA Ends
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...
pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Transfer RNA Synthesis
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...

